1156. Real-World Effectiveness of Recombinant Zoster Vaccine in Chinese Adults Aged ≥50 Years in the US

BACKGROUND: Following the May 2019 approval of recombinant zoster vaccine (RZV) in China, there was a need for real-world information on the vaccine effectiveness (VE) of RZV in a Chinese population. We conducted a retrospective cohort study at Kaiser Permanente Southern California (KPSC) to estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Florea, Ana, Sy, Lina S, Qian, Lei, Ackerson, Bradley, Luo, Yi, Wu, Jun, Cheng, Yanjun, Ku, Jennifer H, Vega Daily, Leticia I, Takhar, Harpreet, Song, Jeannie, Chmielewski-Yee, Elizabeth, Spence, O M areen, Seifert, Harry, Oraichi, Driss, Tseng, Hung Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676851/
http://dx.doi.org/10.1093/ofid/ofad500.996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676851/
http://dx.doi.org/10.1093/ofid/ofad500.996

Ejemplares similares